Has rheumatoid arthritis become a milder disease?

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 3, 2005, Pages 331-336

  Uhlig, Till ^a   Kvien, Tore K ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIINFLAMMATORY AGENT; AUROTHIOMALATE; CHLOROQUINE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 1; LEFLUNOMIDE; METHOTREXATE; PLACEBO; PREDNISONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG SUBSTITUTION; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH STATUS; HUMAN; INCIDENCE; JOINT RADIOGRAPHY; JOINT SURGERY; OUTCOMES RESEARCH; PREVALENCE; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT;

EID: 33645080670     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.08.012     Document Type: Review

References (40)

1. A. Silman et. al. Is rheumatoid arthritis becoming less severe? J. Chronic Dis. 36 1983 891-897
2. T.K. Kvien et. al. The prevalence and severity of rheumatoid arthritis in Oslo: Results from a county register and a population survey Scand. J. Rheumatol. 26 1997 412-418
3. T. Uhlig T.K. Kvien Is rheumatoid arthritis disappearing? Ann. Rheum. Dis. 64 2005 7-10
4. M.M. Ward J.F. Fries Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996 J. Rheumatol. 25 1998 408-416
5. T.M. Sokka et. al. Conventional monotherapy compared to a "sawtooth" treatment strategy in the radiographic progression of rheumatoid arthritis over the first eight years Clin. Exp. Rheumatol. 17 1999 527-532
6. L.R. Lard et. al. Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage Arthritis Rheum. 46 2002 899-905
7. J. Van Aken et. al. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis Ann. Rheum. Dis. 63 2004 274-279
8. J.M. Albers et. al. Treatment strategy, disease activity, and outcome in four cohorts of patients with early rheumatoid arthritis Ann. Rheum. Dis. 60 2001 453-458
9. T. Möttönen et. al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis Arthritis Rheum. 46 2002 894-898
10. A.A. Stenger et. al. Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression Br. J. Rheumatol. 37 1998 1157-1163
11. A. Van der Heide et. al. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial Ann. Intern. Med. 124 1996 699-707
12. S.M. Verstappen et. al. Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year Arthritis Rheum. 48 2003 1797-1807
13. V.P. Nell et. al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis Rheumatology 43 2004 906-914
14. M.A. Bukhari et. al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study Arthritis Rheum. 48 2003 46-53
15. N.J. Wiles et. al. Reduced disability at five years with early treatment of inflammatory polyarthritis: Results from a large observational cohort, using propensity models to adjust for disease severity Arthritis Rheum. 44 2001 1033-1042
16. R.B. Landewé et. al. COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention Arthritis Rheum. 46 2002 347-356
17. T. Möttönen et. al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial. FIN-RACo trial group Lancet 353 1999 1568-1573
18. C. Grigor et. al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial Lancet 364 2004 263-269
19. T. Uhlig et. al. The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up Rheumatology 39 2000 732-741
20. D.M. Van der Heijde et. al. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis Lancet 1 1989 1036-1038
21. K.W. Drossaers-Bakker et. al. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup Arthritis Rheum. 47 2002 383-390
22. M.C. Hochberg et. al. Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis Ann. Rheum. Dis. 62 Suppl. 2 2003 ii13-ii16
23. D.T. Felson et. al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum. 38 1995 727-735
24. L. Klareskog et. al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial Lancet 363 2004 675-681
25. R.N. Maini et. al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate Arthritis Rheum. 50 2004 1051-1065
26. D.E. Furst et. al. Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases Ann. Rheum. Dis. 63 Suppl. 2 2004 ii2-ii12
27. T. Pincus L.F. Callahan Taking mortality in rheumatoid arthritis seriously - predictive markers, socioeconomic status and comorbidity J. Rheumatol. 13 1986 841-845
28. S.E. Gabriel et. al. Survival in rheumatoid arthritis: A population-based analysis of trends over 40 years Arthritis Rheum. 48 2003 54-58
29. L. Björnadål et. al. Decreasing mortality in patients with rheumatoid arthritis: Results from a large population based cohort in Sweden, 1964-65 J. Rheumatol. 29 2002 906-912
30. E. da Silva et. al. Declining use of orthopedic surgery in patients with rheumatoid arthritis? Results of a long-term, population-based assessment Arthritis Rheum. 49 2003 216-220
31. T. Sokka et. al. Radiographic progression is getting milder in patients with early rheumatoid arthritis. Results of 3 cohorts over 5 years J. Rheumatol. 31 2004 1073-1082
32. L.M. Jansen et. al. Comparison of the baseline disease activity of early oligo- and polyarthritis in sequential years Clin. Exp. Rheumatol. 22 2004 447-452
33. T.K. Kvien T. Uhlig The Oslo experience with arthritis registries Clin. Exp. Rheumatol. 21 Suppl. 31 2003 S118-S122
34. T. Heiberg et. al. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis Ann. Rheum. Dis. 64 2005 191-195
35. E. Krishnan J.F. Fries Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998: A longitudinal study of 3035 patients Am. J. Med. 115 2003 371-376
36. T. Pincus et. al. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985 Arthritis Rheum. 52 2005 1009-1019
37. H.K. Choi et. al. Methotrexate and mortality in patients with rheumatoid arthritis: A prospective study Lancet 359 2002 1173-1177
38. O. Kaipiainen-Seppánen et. al. Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990 Clin. Exp. Rheumatol. 14 1996 537-542
39. T. Uhlig et. al. The incidence and severity of rheumatoid arthritis, results from a county register in Oslo Norway J. Rheumatol. 25 1998 1078-1084
40. J. Dadoniene et. al. Disease activity and health status in rheumatoid arthritis: A case-control comparison between Norway and Lithuania Ann. Rheum. Dis. 62 2003 231-235